Get the Stockscreener App
0.5385
3.56%
0.0185
Reviva Pharmaceuticals Holdings Inc stock is traded at $0.5385, with a volume of 2.69M.
It is up +3.56% in the last 24 hours and up +31.12% over the past month.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
See More
Previous Close:
$0.52
Open:
$0.52
24h Volume:
2.69M
Relative Volume:
1.16
Market Cap:
$25.85M
Revenue:
-
Net Income/Loss:
$-27.11M
P/E Ratio:
-0.8285
EPS:
-0.65
Net Cash Flow:
$-26.55M
1W Performance:
-0.28%
1M Performance:
+31.12%
6M Performance:
-65.70%
1Y Performance:
-40.16%
1-Day Range:
$0.5162
$0.5648
1-Week Range:
$0.488
$0.5648
52-Week Range:
$0.30
$4.28
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Name
Reviva Pharmaceuticals Holdings Inc
Sector
Industry
Phone
(408) 501-8881
Address
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.5385 | 35.31M | 0 | -27.11M | -26.55M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-20-23 | Initiated | ROTH MKM | Buy |
| Jun-08-23 | Initiated | The Benchmark Company | Speculative Buy |
| Jan-24-22 | Initiated | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News
Volume spikes in Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock – what they meanTrade Entry Summary & Detailed Earnings Play Strategies - Newser
Can Reviva Pharmaceuticals Holdings Inc. recover in the next quarterEarnings Risk Summary & Real-Time Price Movement Reports - Newser
How to use a screener to detect Reviva Pharmaceuticals Holdings Inc. Equity Warrant breakoutsMarket Sentiment Report & Technical Analysis for Trade Confirmation - Newser
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock bottoming out2025 Top Decliners & Free High Return Stock Watch Alerts - Newser
Does Cobenfy Have the Potential to Become a Top Drug for BMY? - TradingView
How to forecast Reviva Pharmaceuticals Holdings Inc. trends using time series2025 Pullback Review & Capital Efficient Trade Techniques - Newser
Institutional scanner results for Reviva Pharmaceuticals Holdings Inc.Market Risk Report & Capital Efficiency Focused Ideas - Newser
How to read the order book for Reviva Pharmaceuticals Holdings Inc. Equity WarrantMarket Performance Recap & Risk Controlled Swing Trade Alerts - Newser
Signal strength of Reviva Pharmaceuticals Holdings Inc. stock in tech scanners2025 Fundamental Recap & AI Driven Stock Reports - Newser
Best data tools to analyze Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockJuly 2025 Closing Moves & Long-Term Capital Growth Strategies - Newser
Volume spikes in Reviva Pharmaceuticals Holdings Inc. stock – what they meanQuarterly Investment Review & AI Enhanced Execution Alerts - Newser
Analyzing Reviva Pharmaceuticals Holdings Inc. with risk reward ratio chartsJuly 2025 Outlook & Daily Momentum Trading Reports - Newser
Understanding Reviva Pharmaceuticals Holdings Inc.’s price movementGap Up & AI Forecast Swing Trade Picks - Newser
Identifying reversal signals in Reviva Pharmaceuticals Holdings Inc.Market Growth Report & Risk Managed Investment Entry Signals - Newser
Identifying reversal signals in Reviva Pharmaceuticals Holdings Inc. Equity WarrantTake Profit & Reliable Price Action Trade Plans - Newser
Is Reviva Pharmaceuticals Holdings Inc. stock poised for growthCEO Change & AI Driven Price Predictions - Newser
Real time pattern detection on Reviva Pharmaceuticals Holdings Inc. stockJuly 2025 Selloffs & Safe Capital Growth Tips - Newser
Trend analysis for Reviva Pharmaceuticals Holdings Inc. Equity Warrant this weekWeekly Profit Recap & AI Optimized Trade Strategies - Newser
Using RSI to spot recovery in Reviva Pharmaceuticals Holdings Inc. Equity WarrantWeekly Trend Summary & Comprehensive Market Scan Insights - Newser
Chart based exit strategy for Reviva Pharmaceuticals Holdings Inc. Equity WarrantEarnings Overview Report & Community Consensus Stock Picks - Newser
What Fibonacci levels say about Reviva Pharmaceuticals Holdings Inc. reboundJuly 2025 Setups & Consistent Growth Equity Picks - Newser
Reviva Pharmaceuticals Advances Schizophrenia Treatment - MSN
How to manage a losing position in Reviva Pharmaceuticals Holdings Inc. Equity WarrantMarket Trend Summary & Real-Time Market Sentiment Reports - Newser
Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock prediction for this weekJuly 2025 Spike Watch & Weekly Chart Analysis and Trade Guides - Newser
What to expect from Reviva Pharmaceuticals Holdings Inc. Equity Warrant in the next 30 daysFed Meeting & Intraday High Probability Alerts - Newser
Intraday pattern recognizer results for Reviva Pharmaceuticals Holdings Inc.Portfolio Risk Report & Safe Swing Trade Setup Alerts - Newser
How to monitor Reviva Pharmaceuticals Holdings Inc. with trend dashboardsJuly 2025 Final Week & Capital Protection Trading Alerts - Newser
Building trade automation scripts for Reviva Pharmaceuticals Holdings Inc. Equity WarrantJuly 2025 PreEarnings & Consistent Profit Trading Strategies - Newser
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant rally from current levelsPortfolio Return Report & Real-Time Market Sentiment Alerts - Newser
News impact scoring models applied to Reviva Pharmaceuticals Holdings Inc.Portfolio Gains Summary & Safe Capital Growth Trade Ideas - Newser
Custom watchlist performance reports with Reviva Pharmaceuticals Holdings Inc. Equity WarrantJuly 2025 Breakouts & Expert-Curated Trade Recommendations - Newser
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant recover in the next quarter2025 Top Gainers & Risk Controlled Daily Trade Plans - Newser
Risk vs reward if holding onto Reviva Pharmaceuticals Holdings Inc. Equity Warrant2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - Newser
Detecting price anomalies in Reviva Pharmaceuticals Holdings Inc. with AITrade Entry Summary & Community Verified Watchlist Alerts - Newser
What moving averages say about Reviva Pharmaceuticals Holdings Inc.Trade Exit Report & Advanced Swing Trade Entry Plans - Newser
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):